Skip to content
Tenfell
Awarded contract
Published 30 Jan 2026

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

NHS England · London

Key facts

Awarded
05 Jan 2026
Contract starts
01 Feb 2026
Contract ends
30 Sep 2027
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 9 suppliers

SupplierValue
Celix Pharma Ltd.—
Dr Reddy's Laboratories (UK) Ltd—
Teva UK Ltd—
Thornton & Ross Ltd—
Accord-UK Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Glenmark Pharmaceuticals Europe Ltd—
FARMAK PHARMACEUTICALS UK LTD—

Description

Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.